Melissa Eisen - Concepedia

Author

Melissa Eisen

Amgen (United States)

Also Known As

Eisen, Melissa, M Eisen, M. Eisen, Melissa Eisen, Melissa Jeanne Eisen

Publications

963

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Amgen (United Kingdom)Cornell University Bleeding & Clotting Disorders Institute Hospital for Sick Children

About

Melissa Eisen is an author at Amgen (United States) specializing in thrombosis, pediatrics, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	169
2	Emergency Medicine	1	1	22
3	Hospital Medicine	1	1	22
4	Immunology	1	1	147
5	Autoimmune Disease	1	1	147

Melissa Eisen

Publications

811

Citations

H-Index

Page 1

	Year	Citations
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study Adrian C. Newland, Bertrand Godeau, Victor Priego, British Journal of Haematology	2015	171
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study Michael D. Tarantino, James B. Bussel, Victor S. Blanchette, The Lancet ThrombopoiesisThrombosisBone Marrow FailureAutoimmune DiseaseBlood Platelet	2016	147
Use of Sedation for Routine Diagnostic Upper Gastrointestinal Endoscopy: A European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society Members Spiros D. Ladas, Lars Aabakken, J.-F. Rey, Digestion	2006	69
Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP) James B. Bussel, Loan Hsieh, George R. Buchanan, Pediatric Blood & Cancer	2014	64
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (<scp>ITP</scp>) for up to 1 year and in those with chronic <scp>ITP</scp> for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies David J. Kuter, Adrian C. Newland, Beng H. Chong, British Journal of Haematology	2019	64
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia Douglas B. Cines, Jeffrey S. Wasser, Francesco Rodeghiero, Haematologica	2017	62
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents Susan D. Mathias, Xiaoyan Li, Melissa Eisen, Pediatric Blood & Cancer	2016	45
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia Michael D. Tarantino, James B. Bussel, Victor S. Blanchette, Haematologica	2019	31
Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim James B. Bussel, Xuena Wang, Angela Lopez, Hematology	2015	30
Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level Hassam Baig, Barbara Somlo, Melissa Eisen, Journal of Oncology Pharmacy Practice	2018	26

Page 1